Studies of clinical populations that combine MRI data generated at multiple sites are
increasingly common. The Canadian Biomarker Integration Network in Depression (CAN …

A key objective in the field of translational psychiatry over the past few decades has been to
identify brain biomarkers of major depressive disorder (MDD) to support the development of …

A growing number of studies have used neuroimaging to further our understanding of how
brain structure and function are altered in major depression. More recently, these techniques …

A key objective in the field of translational psychiatry over the past few decades has been to
identify the brain correlates of major depressive disorder (MDD). Identifying measurable …

Abstract Background Major Depressive Disorder (MDD) is among the most prevalent and
disabling medical conditions worldwide. Identification of clinical and biological markers …

Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge
due to the absence of biomarkers based on physiological parameters or medical tests …

The growth of the literature about neuroimaging of major depressive disorder (MDD) over
the last several decades has contributed to the progress in recognizing precise brain areas …

Background Multiple studies have examined functional and structural brain alteration in
patients diagnosed with major depressive disorder (MDD). The introduction of multivariate …

Over the last few decades, neuroimaging techniques have advanced the identification of
structural, functional, and neurochemical brain abnormalities that are associated with the …

Abstract Background Major Depressive Disorder (MDD) is a leading cause of disease
burden worldwide. With the rapid growth of neuroimaging research on relatively small …